Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Preceptorship on Brain Tumours 2022: Lugano
- Start date
- 23 Jun 2022
- End date
- 24 Jun 2022
- Location
- Lugano, Switzerland
Learning objectives
- To learn about the evidence base for diagnostic imaging, molecular pathology and neurocognitive assessment in brain tumor patients
- To understand the basis of multi-modality treatment of lower and higher-grade gliomas
- To learn about local and systemic treatment options for meningiomas
- To learn about the multi-modality management of brain metastasis patients including targeted therapies in patients with actionable driver mutations and with novel immunotherapies
- To learn about future developments in the management of gliomas, meningiomas, brain metastases and leptomeningeal carcinomatosis
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Giuseppe Minniti, Italy
- Michael Weller, Switzerland
